Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 12, 2018Current Pharmaceutical Design

Coronary Microcirculation and the No-reflow Phenomenon

View Full Paper
Ask AI
Bookmark
Share

Population

Patients undergoing percutaneous coronary intervention who experience the no-reflow phenomenon

Design

Review

Authors

EOEvangelos OikonomouKMKonstantinos MourouzisGVGeorgia Vogiatzi

Discussion

Loading...

Member takes

Overview

Pathophysiology of no-reflow remains incompletely understood; leaves open mechanism-specific therapies to improve post-PCI perfusion.

Structured PICO

P
Population
Patients undergoing percutaneous coronary intervention who experience the no-reflow phenomenon
I
Intervention
Preventive and therapeutic interventions for no-reflow

This review summarizes current understanding of the pathophysiology and management strategies for the no-reflow phenomenon following percutaneous coronary intervention.

Cite This Study

Oikonomou et al. (2018) studied this question.

synapsesocial.com/papers/6a70dc65a7fbea1e44083d1dhttps://doi.org/10.2174/1381612824666180911122230
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevention and Treatment of No-Reflow Phenomenon by Targeting the Coronary Microcirculation2014 · 37 citations
  2. 2Coronary No-Reflow Phenomenon in Clinical Practice2018 · 29 citations
  3. 3NO-REFLOW PHENOMENON – MECHANISM, PREVENTION AND TREATMENT STRATEGIES2026
  4. 4«No-reflow» phenomenon: clinical aspects of reperfusion failure2015 · 16 citations
  5. 5Pathophysiology, Diagnosis, and Management of Coronary No-Reflow Phenomenon2022 · 10 citations